Skip to main content

Table 3 Patient primary site distribution

From: Epithelial-myoepithelial carcinoma: a population-based survival analysis

Primary site

Abdominal esophagus

1

0.2%

Accessory sinus, NOS

1

0.2%

Anterior wall of nasopharynx

2

0.4%

Axillary tail of breast

1

0.2%

Base of tongue, NOS

2

0.4%

Breast, NOS

4

0.9%

Central portion of breast

2

0.4%

Cervical esophagus

1

0.2%

Cheek mucosa

5

1.1%

Conn, subcutaneous, other soft tis: lower limb, hip

1

0.2%

Conn, subcutaneous, other soft tis: trunk, NOS

2

0.4%

Conn, subcutaneous, other soft tis: upr limb, shoulder

1

0.2%

Endometrium

2

0.4%

Ethmoid sinus

1

0.2%

External ear

2

0.4%

Floor of mouth, NOS

2

0.4%

Hard palate

10

2.1%

Head, face or neck, NOS

1

0.2%

Lacrimal gland

1

0.2%

Lateral wall of nasopharynx

1

0.2%

Lower lobe, lung

3

0.6%

Lower-inner quadrant of breast

1

0.2%

Lower-outer quadrant of breast

1

0.2%

Lung, NOS

2

0.4%

Main bronchus

3

0.6%

Major salivary gland, NOS

14

3.0%

Maxillary sinus

5

1.1%

Middle lobe, lung

1

0.2%

Mouth, NOS

1

0.2%

Nasal cavity

6

1.3%

Nasopharynx, NOS

3

0.6%

Ovary

11

2.4%

Overlapping lesion of breast

5

1.1%

Overlapping lesion of floor of mouth

1

0.2%

Overlapping lesion of lung

1

0.2%

Overlapping lesion of major salivary glands

1

0.2%

Overlapping lesion of palate

1

0.2%

Overlapping lesion of rectum, anus, and anal canal

1

0.2%

Overlapping lesion of tongue

1

0.2%

Parotid gland

270

57.7%

Posterior wall of nasopharynx

2

0.4%

Pyriform sinus

1

0.2%

Retromolar area

1

0.2%

Sigmoid colon

1

0.2%

Skin of scalp and neck

2

0.4%

Skin other/unspec parts of face

1

0.2%

Soft palate, NOS

5

1.1%

Sublingual gland

1

0.2%

Submandibular gland

46

9.8%

Tonsillar fossa

1

0.2%

Trachea

3

0.6%

Unknown primary site

14

3.0%

Upper gum

1

0.2%

Upper lobe, lung

2

0.4%

Upper-inner quadrant of breast

2

0.4%

Upper-outer quadrant of breast

10

2.1%